W
William A. Blattner
Researcher at University of Maryland, Baltimore
Publications - 345
Citations - 26953
William A. Blattner is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Population & Virus. The author has an hindex of 80, co-authored 345 publications receiving 26023 citations. Previous affiliations of William A. Blattner include RTI International & Boston University.
Papers
More filters
Journal ArticleDOI
Patterns of HIV-1 and HTLV-I/II in Intravenous Drug Abusers from the Middle Atlantic and Central Regions of the USA
Hans Lee,Stanley H. Weiss,Lawrence S. Brown,Donna Mildvan,Vernon S. Shorty,Louis Saravolatz,Alvin Chu,Harold M. Ginzburg,Norman Markowitz,Don C. Des Jarlais,William A. Blattner,Jean-Pierre Allain +11 more
TL;DR: The contrast between the two classes of virus suggests that HIV-1 is more efficiently transmitted, while the age-dependent rise in HTLV-I/II seroprevalence suggests cumulative exposure of a less-transmissible agent.
Journal ArticleDOI
Effects of a urinary factor from women in early pregnancy on HIV-1, SIV and associated disease
Yanto Lunardi-Iskandar,Joseph Bryant,William A. Blattner,Chia Ling Hung,Louis Flamand,Louis Flamand,Parkash Gill,Phillipe Hermans,Steven Birken,Robert C. Gallo +9 more
TL;DR: Using gel permeation chromatography of the clinical grade hCC and urine concentrates from pregnant women, it is demonstrated that an as yet unidentified hCG associated factor (HAF) with anti-HIV, anti-SIV,Anti-KS and pro-hematopoietic activities elutes as two peaks corresponding to 15–30 kDa and 2–4 kDa.
Journal ArticleDOI
HIV Infection-induced Posttranslational Modification of T Cell Signaling Molecules Associated with Disease Progression
Irena Stefanova,M W Saville,C Peters,Farley R. Cleghorn,David A. Schwartz,David Venzon,Kent J. Weinhold,Noreen Jack,Courtenay Bartholomew,William A. Blattner,Robert Yarchoan,Joseph B. Bolen,Ivan D. Horak +12 more
TL;DR: Modification of T cell PTKs may underlie the HIV-induced impairment of lymphocyte function and may potentially predict disease progression.
Guidelines for counseling persons infected with human T-lymphotropic virus type I (HTLV-I) and type II (HTLV-II)
Rima F. Khabbaz,Keiji Fukuda,Jonathan E. Kaplan,Cielso Bianco,William A. Blattner,Michael P. Busch,Roger Y. Dodd,Jay S. Epstein,Ronald O. Gilcher,Craig Jackson,Louis M. Katz,Steven Kleinman,Edward L. Murphy,George J. Nemo,Bernard J. Poiesz,Maria Rios,Elaine M. Sloand,Marian T. Sullivan,Alan E. Williams +18 more
TL;DR: Investigational peptide- and recombinant protein-based serologic assays that can more easily differentiate between antibodies to HTLV-I andHTLV-II have been developed and preliminary data suggest that these investigational tests are potentially useful for typing serum samples.
Journal ArticleDOI
Prevalence of Non-Tuberculous Mycobacterial Infections among Tuberculosis Suspects in Nigeria
Gambo Aliyu,Samer S. El-Kamary,Alash'le Abimiku,Clayton H. Brown,Kathleen Tracy,Laura L. Hungerford,William A. Blattner +6 more
TL;DR: The high proportion of younger patients with clinical pulmonary TB due to NTM and co-infection with HIV and the likely role of the seasonal dust exposure in the occurrence of the disease, present novel public health challenges for prevention and treatment.